The impact of loco-regional treatment on ipsilateral breast cancer recurrence and outcomes in carriers of BRCA1/2 pathogenic variants
The timing and rates of LRRs differ according to the loco-regional therapy, which might indicate a different etiology driving these events.
Authors
- Ory Haisraely
- P. Poortmans
- Tehillah S. Menes (ORCID: https://orcid.org/0000-0001-7988-3747)
- Einav Nili Gal‐Yam (ORCID: https://orcid.org/0000-0003-1059-7923)
- Rinat Bernstein‐Molho (ORCID: https://orcid.org/0000-0002-4068-9514)
- Orit Kaidar-Person
- Shira Galper
- Narmeen Abu-Shhada
Institutions
- University of Antwerp (BE)
- Tel Aviv University (IL)
- Sheba Medical Center (IL)
- Maastricht University (NL)
- Iridium Kankernetwerk (BE)
Publication Details
- Journal
- Breast Cancer Research and Treatment
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1007/s10549-025-07658-x
- Citations
- 3
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 5.45
Funders
- Tel Aviv University